Biomimetic Artificial Antigen Presenting Cells Synergize with Anti-PD1 in the Treatment of Melanoma

被引：0
|
作者：
Meyer, Randall A. [1 ]
Kosmides, Alyssa K. [1 ]
Hickey, John W. [1 ]
Aje, Kent [2 ]
Cheung, Ka Ho Nicholas [1 ]
Schneck, Jonathan P. [2 ]
Green, Jordan J. [1 ]
机构：
[1] Johns Hopkins Univ, Biomed Engn, Baltimore, MD USA
[2] Johns Hopkins Univ, Pathol, Baltimore, MD USA
来源：
MOLECULAR THERAPY | 2017年 / 25卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
583
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [1] Biomimetic biodegradable artificial antigen presenting with PD-1 blockade to treat melanoma cells synergize
    Kosmides, A. K.
    Meyer, R. A.
    Hickey, J. W.
    Aje, K.
    Cheung, K. N.
    Green, J. J.
    Schneck, J. P.
    [J]. BIOMATERIALS, 2017, 118 : 16 - 26
  • [2] Anti-PD1 role in treatment of cutaneous melanoma
    Mateus, Christine
    Libenciuc, Cristina
    Robert, Caroline
    [J]. BULLETIN DU CANCER, 2016, 103 (06) : S4 - S11
  • [3] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    [J]. MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
  • [4] Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
    van der Kooij, M. K.
    Joosse, A.
    Speetjens, F. M.
    Hospers, G. A. P.
    Bisschop, C.
    de Groot, J. W. B.
    Koornstra, R.
    Blank, C. U.
    Kapiteijn, E.
    [J]. ACTA ONCOLOGICA, 2017, 56 (01) : 101 - 103
  • [5] Change of laboratory parameters during anti-PD1 treatment in patients with melanoma
    Janka, E. A.
    Vanyai, B.
    Varvolgyi, T.
    Remenyik, E.
    Emri, G.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S303 - S303
  • [6] Anti-PD1 treatment of advanced melanoma: development of criteria for a safe stop
    Lorigan, P.
    Eggermont, A. M. M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (07) : 1038 - 1040
  • [7] Systemic analysis of innate responses to anti-PD1/PD-L1 treatment in a melanoma model
    Gassen, Rodrigo
    Welm, Alana
    Bonorino, Cristina
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [8] Intralesional anti-PD1 treatment in patients with metastatic melanoma: The pilot study.
    Samoylenko, Igor
    Korotkova, Olga V.
    Zabotina, Tatiana
    Demidov, Lev V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [9] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [10] Enhancer reprogramming contributes to anti-PD1 resistance in melanoma
    Maitituoheti, Mayinuer
    Tang, Ming
    Terranova, Christopher J.
    Keung, Emily
    Tomczak, Katarzyna J.
    Wargo, Jennifer
    Rai, Kunal
    [J]. CANCER RESEARCH, 2020, 80 (16)
12345